Recall: D-0738-2022

Class II - Potentially Harmful

Class IIClassification

2022-03-23Initiated

TerminatedStatus

Dr. Reddy's Laboratories, Inc.Firm

Product

Lansoprazole Delayed-Release Capsules, USP, 30 mg, 90-count bottle, Rx Only, Manufactured By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090, India, NDC 55111-399-90.

Reason

Failed Dissolution Specifications; during long term stability testing.

Distribution

Nationwide in the USA

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.